Mahesh Asawa Chandra
Direttore/Membro del Consiglio presso Unidrug Innovative Pharma Technologies Ltd.
Profilo
Mahesh Asawa Chandra is currently an Independent Director at Unidrug Innovative Pharma Technologies Ltd.
and a Fellow Member at The Institute of Chartered Accountants of India.
He has an undergraduate and graduate degree from Devi Ahilya University.
Posizioni attive di Mahesh Asawa Chandra
Società | Posizione | Inizio |
---|---|---|
Unidrug Innovative Pharma Technologies Ltd.
Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Direttore/Membro del Consiglio | 20/09/2018 |
The Institute of Chartered Accountants of India | Corporate Officer/Principal | - |
Formazione di Mahesh Asawa Chandra
Devi Ahilya University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Unidrug Innovative Pharma Technologies Ltd.
Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Health Technology |
- Borsa valori
- Insiders
- Mahesh Asawa Chandra